Optipharm.CO.,LTD (KOSDAQ:153710)
South Korea · Delayed Price · Currency is KRW 5,080.00
+40.00 (0.79%)
At close: Mar 27, 2026
Optipharm.CO.,LTD Revenue
In the year 2025, Optipharm.CO.,LTD had annual revenue of 22.34B KRW with 13.79% growth. Optipharm.CO.,LTD had revenue of 5.96B in the quarter ending December 31, 2025, with 6.51% growth.
Revenue
22.34B
Revenue Growth
+13.79%
P/S Ratio
3.34
Revenue / Employee
n/a
Employees
n/a
Market Cap
74.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.34B | 2.71B | 13.79% |
| Dec 31, 2024 | 19.64B | 2.26B | 13.03% |
| Dec 31, 2023 | 17.37B | 1.36B | 8.52% |
| Dec 31, 2022 | 16.01B | 1.75B | 12.27% |
| Dec 31, 2021 | 14.26B | 1.21B | 9.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ahn-Gook Pharmaceutical | 306.87B |
| Cosmax Nbt | 287.48B |
| H.PIO | 257.56B |
| Jin Yang Pharmaceutical | 117.19B |
| Sinsin Pharmaceutical | 110.29B |
| Hwail Pharmaceutical | 107.87B |
| Sinil Pharmaceutical | 80.56B |
| Sam-A Pharm. | 76.66B |